EDGAR Filing Documents for 0001144204-12-040012

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001144204-12-040012

Filing Date

2012-07-18

Accepted

2012-07-18 16:49:29

Documents

Effectiveness Date

2012-07-18

Items

Item 06: Rule 506

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	8271
	Complete submission text file	0001144204-12-040012.txt		9276

Mailing Address 1620 BEACON PLACE OXNARD CA 93033

Business Address 1620 BEACON PLACE OXNARD CA 93033 805 824 0410

CURE PHARMACEUTICAL Corp (Filer) CIK: 0001554289 (see all company filings)